Adaptation of Chinese and English versions of the Psoriatic Arthritis Quality of Life (PsAQoL) scale for use in Singapore

BMC Musculoskeletal Disorders

Research Article

Ying Ying Leung¹  Julian Thumboo¹  Matthew Rouse²  Stephen P. McKenna³ 

[1] Department of Rheumatology & Immunology, Singapore General Hospital, The Academia, level 4, 20 College Road, S169856, Singapore, Singapore;Duke-NUS Medical School, Singapore, Singapore;Galen Research Ltd, Manchester, UK;School of Health Sciences, University of Manchester, Manchester, UK;

关键词: Psoriatic arthritis;    Quality of life;    outcome measures;    cross cultural adaptation;   

DOI  :  10.1186/s12891-016-1292-4

 received in 2016-07-08, accepted in 2016-10-11,  发布年份 2016

来源: Springer

【 摘 要 】

BackgroundTo develop Singapore Chinese and English versions of the Psoriatic Arthritis Quality of Life (PsAQoL) scale that were equivalent to and met the same psychometric and acceptability standards as the original UK measure.MethodsTranslation of the original PsAQoL into contextualised English and Chinese versions for use in Singapore was performed by professional and lay translation panels. Ten Chinese speaking and ten English speaking local patients were interviewed to assess face and content validity. Psoriatic arthritis (PsA) patients (either Chinese or English speaking) fulfilling the Classification criteria of Psoriatic Arthritis were then invited to participate in a validation survey. Clinical variables, the Health Assessment Questionnaire (HAQ) and the Medical Outcome Short-form 36 (SF-36) were used as comparator instruments for convergent validity. A separate sample of PsA patients were invited to participate in a test-retest postal study, with two weeks between administrations.ResultsThe validation sample included 98 patients (51 % men) with a mean (SD) age of 51.5 (13.8) years. The PsAQoL had excellent internal consistency (Cronbach’s α = 0.92) and scores on the measure were moderately correlated with health status measures (pain, HAQ score, SF-36 scores) and patient and physician global assessments. The scale was able to distinguish between groups with active or inactive disease assessed by composite scores, HAQ and minimal disease activity. Test–retest reliability was excellent (r = 0.92).ConclusionsThis study provides evidence that the adapted English and Chinese versions of the PsAQoL can be used in clinical studies with PsA patients in Singapore.

【 授权许可】

CC BY   
© The Author(s). 2016